Invasive Pleomorphic Lobular Carcinoma of The Male Breast: A Rare Diagnosis with Radiologic-Pathologic Correlation
Keywords:Breast Neoplasms, Male, Carcinoma, Lobular Magnetic Resonance Imaging, Mammography
Male breast cancer is a rare disease, representing approximately 1% of all breast cancers, but its incidence appears to be increasing over the years. As normal male breast does not develop acini and lobules, lobular carcinoma is very rare, accounting for 1% - 2% of all cases of male breast cancer. Pleomorphic lobular carcinoma is an aggressive variant of invasive lobular carcinoma with only six cases of male breast reported in the literature until now, and none with associated Paget’s disease. We report a case of an invasive pleomorphic lobular carcinoma with axillary lymph node involvement and associated Paget’s disease in a high-risk man. Low awareness among men and a lack of a screening program often lead to a late diagnosis of male breast cancer, and consequently, at a later stages of disease, with lower survival rates compared to women. Early diagnosis is essential in order to improve patient outcomes and achieve better survival rates in men.
Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10:471-9. DOI: https://doi.org/10.1634/theoncologist.10-7-471
Giordano SH. Breast cancer in men. N Engl J Med. 2018;378:2311-20. DOI: https://doi.org/10.1056/NEJMra1707939
Panigrahi B, Miles RC, Chou SS, Brackett DG, Sohn YJ, Lehman C. Rare case of invasive lobular carcinoma in a male. Radiol Case Rep. 2020;15:727-9. DOI: https://doi.org/10.1016/j.radcr.2020.02.005
Senger JL, Adams SJ, Kanthan R. Invasive lobular carcinoma of the male breast - a systematic review with an illustrative case study. Breast Cancer. 2017;9:337-45. DOI: https://doi.org/10.2147/BCTT.S126341
Murzabdillaeva A, Ali Y, Aakash N, Armstrong J, Ghorbani R, Zhang S. Pleomorphic invasive lobular carcinoma of the male breast: two case reports with opposite hormone receptor status. Ann Clin Lab Sci. 2019;49:534-8.
Expert Panel on Breast Imaging: Niell BL, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, et al. ACR Appropriateness Criteria® evaluation of the symptomatic male breast. J Am Coll Radiol. 2018;15:S313-20. DOI: https://doi.org/10.1016/j.jacr.2018.09.017
Shaw A, Smith B, Howlett D. Male breast carcinoma and the use of MRI. Radiol Case Rep. 2015;6:455. DOI: https://doi.org/10.2484/rcr.v6i3.455
The Royal College of Radiologists. Guidance on screening and symptomatic breast imaging. 4th ed. The Royal College of Radiologists. 2019. [cited 2019 Nov 29]. Available from: https: //www.rcr.ac.uk/publication/guidance-screening-and-symptomatic-breast-imagingfourth-edition.
How to Cite
Copyright (c) 2022 Acta Médica Portuguesa - Ordem dos Médicos
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.